Streetbeat News

Products Services

GOOG

GOOGL

Google is set to enforce new requirements for advertisers promoting financial services in Ireland, New Zealand, South Korea, and Thailand. The updated financial services verification process policy will be implemented starting November 7.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:39 pm

ACB

CGC

TLRY

Canopy Growth Corp. (NASDAQ:CGC) is focusing on a 'brand-first' strategy through its Canopy USA entity, which includes brands like Wana and Jetty. Analyst Pablo Zuanic suggests this positions Canopy for growth, especially with potential federal regulatory changes. Canopy's asset-light approach contrasts with Canadian peers like Tilray and Aurora, focusing on brand expansion rather than cultivation.

Portfolio Pulse from Nicolás Jose Rodriguez

October 08, 2024 | 2:38 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides a detailed analysis of key price levels for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. The memo suggests monitoring these stocks for potential breakouts or reversals, with specific bullish and bearish targets outlined for each. The day is expected to be driven by technical factors due to a lack of major economic data releases.

Portfolio Pulse from RIPS

October 08, 2024 | 2:38 pm

VINC

Vincerx Pharma (NASDAQ:VINC) is seeking a development partner for its early-stage blood cancer candidates, VIP236 and enitociclib, while focusing on its lead ADC, VIP943. The company shared updates on its Phase 1 studies, showing promising results for VIP943 and VIP236. VINC stock is down 25.3% at $0.52.

Portfolio Pulse from Vandana Singh

October 08, 2024 | 2:38 pm

PTCT

PTC Therapeutics shares rise as its Vatiquinone Friedreich Ataxia program meets endpoints in two long-term studies. The company has also aligned with the FDA on key aspects of its planned NDA submission.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:37 pm

GK

MSOS

SPY

Investor Ross Gerber emphasizes the importance of rescheduling cannabis, highlighting its harmless nature and medical benefits. He urges action within a month, warning of political consequences if not addressed.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:35 pm

CLX

Goldman Sachs analyst Bonnie Herzog reiterated a Sell rating for Clorox Co (NYSE:CLX) with a price target of $132, citing negative risk/reward ahead of its quarterly earnings. Despite progress in product availability, challenges remain due to competition and promotional needs. Herzog sees downside to current estimates and expects organic sales growth to be back-end loaded in fiscal 2025.

Portfolio Pulse from Priya Nigam

October 08, 2024 | 2:34 pm

GK

MSOS

Investor Ross Gerber highlights cannabis as a major investment opportunity, emphasizing its potential outside of AI. He stresses the importance of diversity, equity, and inclusion (DEI) in the industry and advocates for community support and development.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:31 pm

GK

MSOS

Investor Ross Gerber highlights the potential in the cannabis industry, noting past investment losses but emphasizing future opportunities. He stresses the importance of maintaining high standards and not selling to minors, aiming to position cannabis above alcohol and tobacco industries.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:28 pm

MRK

Merck announced positive results from its Phase 3 KEYNOTE-689 trial for Keytruda in treating head and neck cancer, showing significant improvement in event-free survival and major pathological response. However, overall survival results were not statistically significant. The safety profile remains consistent with previous studies.

Portfolio Pulse from Vandana Singh

October 08, 2024 | 2:28 pm